Evidence map›Paper›PMID 36613640›Full record

ReviewInternational journal of molecular sciences2022

Role of miRNA in Melanoma Development and Progression.

Agata Poniewierska-Baran, Sylwia Słuczanowska-Głąbowska, Paulina Małkowska, Olga Sierawska, Łukasz Zadroga, Andrzej Pawlik, Paulina Niedźwiedzka-Rystwej

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Non-coding RNA profiling in BRAFScientific data · 2025
    Article
  11. Review
  12. The Anticancer Perspective of Tangeretin: A Small Review.Molecules (Basel, Switzerland) · 2025
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Agata Poniewierska-BaranInstitute of Biology, University of Szczecin, 71-412 Szczecin, Poland.ORCID 0000-0001-6719-803X
Sylwia Słuczanowska-GłąbowskaDepartment of Physiology, Pomeranian Medical University in Szczecin, 70-111 Szczecin, Poland.
Paulina MałkowskaDoctoral School of the University of Szczecin, Institute of Biology, University of Szczecin, 71-412 Szczecin, Poland.ORCID 0000-0003-2430-5020
Olga SierawskaDoctoral School of the University of Szczecin, Institute of Biology, University of Szczecin, 71-412 Szczecin, Poland.ORCID 0000-0003-3567-7786
Łukasz ZadrogaPomeranian Medical University in Szczecin, 70-111 Szczecin, Poland.
Andrzej PawlikDepartment of Physiology, Pomeranian Medical University in Szczecin, 70-111 Szczecin, Poland.ORCID 0000-0001-6557-1208
Paulina Niedźwiedzka-RystwejInstitute of Biology, University of Szczecin, 71-412 Szczecin, Poland.ORCID 0000-0003-4065-3842

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Melanoma is one of the most aggressive and progressive skin cancers. It develops from normal pigment-producing cells known as melanocytes, so it is important to know the mechanism behind such transformations. The study of metastasis mechanisms is crucial for a better understanding the biology of neoplastic cells. Metastasis of melanoma, or any type of cancer, is a multi-stage process in which the neoplastic cells leave the primary tumour, travel through the blood and/or lymphatic vessels, settle in distant organs and create secondary tumours. MicroRNA (miRNA) can participate in several steps of the metastatic process. This review presents the role of miRNA molecules in the development and progression as well as the immune response to melanoma.

Indexed as

MelanomaMicroRNAsSkin NeoplasmsGene Expression Regulation, NeoplasticHumansMelanocytesSkinMicroRNAsmelanomamelanoma metastasismelanoma progressionmicroRNAmiRNAskin cancer

Identifiers

PMID36613640
PMCPMC9820801

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.